HDDO-1614 Bio Equivalence Study
NCT03382314
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
COMBINATION_PRODUCT:
HDDO-1614
DRUG:
Bazedoxifene / Cholecalciferol
Sponsor
Hyundai Pharmaceutical Co., LTD.